J. Winer

4.2k total citations
67 papers, 2.4k citations indexed

About

J. Winer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, J. Winer has authored 67 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Neurology, 27 papers in Cellular and Molecular Neuroscience and 9 papers in Epidemiology. Recurrent topics in J. Winer's work include Peripheral Neuropathies and Disorders (33 papers), Hereditary Neurological Disorders (25 papers) and Peripheral Nerve Disorders (6 papers). J. Winer is often cited by papers focused on Peripheral Neuropathies and Disorders (33 papers), Hereditary Neurological Disorders (25 papers) and Peripheral Nerve Disorders (6 papers). J. Winer collaborates with scholars based in United Kingdom, Canada and United States. J. Winer's co-authors include Richard AC Hughes, Clive Osmond, R Watkins, H. O. Kangro, M. J. Anderson, Dylan M. Jones, Ian Sutton, Marinus Vermeulen, Ivo N. van Schaik and Rob de Haan and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Brain.

In The Last Decade

J. Winer

64 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Winer United Kingdom 29 1.6k 1.2k 282 240 216 67 2.4k
Wilfred A. Nix Germany 26 1.5k 0.9× 394 0.3× 274 1.0× 175 0.7× 208 1.0× 83 2.4k
K. V. Toyka Germany 33 2.4k 1.5× 1.8k 1.6× 916 3.2× 397 1.7× 170 0.8× 91 4.1k
Nortina Shahrizaila Malaysia 22 1.3k 0.8× 804 0.7× 286 1.0× 227 0.9× 52 0.2× 93 1.9k
К. Schimrigk Germany 30 1.1k 0.7× 420 0.4× 292 1.0× 174 0.7× 453 2.1× 174 2.8k
Nitya R. Ghatak United States 32 681 0.4× 738 0.6× 427 1.5× 129 0.5× 274 1.3× 88 2.5k
M. K. Sharief United Kingdom 29 714 0.4× 425 0.4× 517 1.8× 135 0.6× 161 0.7× 52 2.4k
Kazim A. Sheikh United States 32 2.1k 1.3× 2.0k 1.7× 589 2.1× 728 3.0× 92 0.4× 73 3.6k
Wilson Marques Brazil 24 602 0.4× 756 0.6× 550 2.0× 204 0.8× 121 0.6× 183 2.1k
Linda Clover United Kingdom 26 1.9k 1.2× 374 0.3× 564 2.0× 64 0.3× 310 1.4× 43 3.0k
Masahiko Kishi Japan 28 1.0k 0.6× 305 0.3× 237 0.8× 72 0.3× 510 2.4× 121 2.3k

Countries citing papers authored by J. Winer

Since Specialization
Citations

This map shows the geographic impact of J. Winer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Winer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Winer more than expected).

Fields of papers citing papers by J. Winer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Winer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Winer. The network helps show where J. Winer may publish in the future.

Co-authorship network of co-authors of J. Winer

This figure shows the co-authorship network connecting the top 25 collaborators of J. Winer. A scholar is included among the top collaborators of J. Winer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Winer. J. Winer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Betteridge, Zoë, Hector Chinoy, Jiří Vencovský, et al.. (2019). Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis. Lara D. Veeken. 59(5). 1026–1030. 13 indexed citations
3.
Rajabally, Yusuf A., Fu Liong Hiew, & J. Winer. (2015). Influence of timing on electrodiagnosis of Guillain–Barré syndrome in the first six weeks: A retrospective study. Journal of the Neurological Sciences. 357(1-2). 143–145. 14 indexed citations
4.
Ibrahim, Fowzia, Ernest Choy, Patrick Gordon, et al.. (2014). Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids. Lara D. Veeken. 54(6). 1050–1055. 20 indexed citations
5.
Gordon, P., Fowzia Ibrahim, Anna Kowalczyk, et al.. (2011). One Year Randomised Controlled Trial of SEcond Line Agents in Myositis (SELAM): Late Additional immunosuppression is Ineffective in Patients Who Have Partially Responded to Steroids. UCL Discovery (University College London). 2 indexed citations
6.
Winer, J.. (2010). Guillain–Barré syndrome: Clinical variants and their pathogenesis. Journal of Neuroimmunology. 231(1-2). 70–72. 27 indexed citations
7.
Winer, J., et al.. (2010). Neurology of endocrine disease. Clinical Medicine. 10(4). 387–390. 5 indexed citations
8.
Edwards, Louisa, Christopher Ring, David McIntyre, Una Martin, & J. Winer. (2009). Effects of essential hypertension on short latency human somatosensory-evoked potentials. Psychophysiology. 47(2). 323–331. 6 indexed citations
9.
Hughes, R. A. C., Robert D. M. Hadden, Mohamed Mahdi‐Rogers, et al.. (2007). A pilot randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial: rationale and protocol). Digital Access to Libraries. 1 indexed citations
10.
Houlden, Henry, Mike Groves, Z Miedzybrodzka, et al.. (2007). New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. Journal of Neurology Neurosurgery & Psychiatry. 78(11). 1267–1270. 27 indexed citations
12.
Sutton, Ian, Jane C. Steele, Caroline O. S. Savage, J. Winer, & Lawrence S. Young. (2004). An interferon-γ ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. Journal of Neuroimmunology. 150(1-2). 98–106. 18 indexed citations
13.
Winer, J.. (2002). Treatment of Guillain-Barre syndrome. QJM. 95(11). 717–721. 19 indexed citations
14.
Schaik, Ivo N. van, J. Winer, Rob de Haan, & Marinus Vermeulen. (2002). Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. The Lancet Neurology. 1(8). 491–498. 40 indexed citations
15.
Winer, J.. (2001). NOSOLOGICAL ENTITIES?: Bickerstaff's encephalitis and the Miller Fisher syndrome. Journal of Neurology Neurosurgery & Psychiatry. 71(4). 433–435. 29 indexed citations
16.
Cader, M. Zameel & J. Winer. (1999). Lesson of the week: Cavernous haemangioma mimicking multiple sclerosis. BMJ. 318(7198). 1604–1605. 7 indexed citations
17.
Khalili-Shirazi, A., Norman A. Gregson, I. A. Gray, et al.. (1999). Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection. Journal of Neurology Neurosurgery & Psychiatry. 66(3). 376–379. 56 indexed citations
18.
Winer, J., et al.. (1998). Thermosensory threshold: a sensitive test of HIV associated peripheral neuropathy?. Journal of NeuroVirology. 4(4). 433–437. 9 indexed citations
19.
Walsh, F S, Michelle Cronin, Simon A. Koblar, et al.. (1991). Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. Journal of Neuroimmunology. 34(1). 43–51. 122 indexed citations
20.
Winer, J., et al.. (1990). Neurosarcoidosis Presenting as Benign Intracranial Hypertension. European Neurology. 30(5). 282–283. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026